Europe PMCopen access
Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases
Regulatory Science, Adaptive Designs, Platform Trials, Trial Innovation, Clinical Trial Authorization
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 5218
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.